thyroxine has been researched along with Granulomatosis with Polyangiitis in 6 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Three groups of patients were prospectively evaluated: Group I: 15 patients with Wegener's granulomatosis and 4 patients with severe scleritis received a single dose cyclophosphamide (15 mg/kg bw/day) and 250 mg prednisone i." | 3.70 | Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). ( Jockenhövel, F; Kummer, G; Mann, K; Philipp, T; Reinhardt, W; Reinwein, D; Sauter, V; Uppenkamp, M; Witzke, O, 1999) |
| "Wegener's granulomatosis is a well-defined systemic vasculitic syndrome that primarily affects the upper and lower respiratory tracts and the kidney." | 1.29 | Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis. ( Gal, AA; LiVolsi, VA; Masor, JJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, O | 1 |
| Kalfa, M | 1 |
| Celebi, ARC | 1 |
| Cabuk, B | 1 |
| Ceylan, S | 1 |
| Triano, MJ | 1 |
| Haberstroh, WD | 1 |
| Lenka, A | 1 |
| Whelton, SA | 1 |
| Gu, Y | 1 |
| Sun, X | 1 |
| Peng, M | 1 |
| Zhang, T | 1 |
| Shi, J | 1 |
| Mao, J | 1 |
| Driedger, AA | 1 |
| Quirk, S | 1 |
| McDonald, TJ | 1 |
| Ledger, S | 1 |
| Gray, D | 1 |
| Wall, W | 1 |
| Yoo, J | 1 |
| Masor, JJ | 1 |
| Gal, AA | 1 |
| LiVolsi, VA | 1 |
| Reinhardt, W | 1 |
| Sauter, V | 1 |
| Jockenhövel, F | 1 |
| Kummer, G | 1 |
| Uppenkamp, M | 1 |
| Witzke, O | 1 |
| Philipp, T | 1 |
| Reinwein, D | 1 |
| Mann, K | 1 |
1 review available for thyroxine and Granulomatosis with Polyangiitis
| Article | Year |
|---|---|
Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Biopsy; Deamino Arginine Vasopressin; Fem | 2019 |
5 other studies available for thyroxine and Granulomatosis with Polyangiitis
| Article | Year |
|---|---|
Granulomatosis With Polyangiitis as an Uncommon Cause of Panhypopituitarism.
Topics: Aged; Antirheumatic Agents; Biopsy; Endoscopy; Female; Granulomatosis with Polyangiitis; Humans; Hyp | 2019 |
Relapsed granulomatosis with polyangiitis with panhypopituitarism.
Topics: Adrenal Insufficiency; Androgens; Diabetes Insipidus; Fatigue; Glucocorticoids; Granulomatosis with | 2021 |
A pragmatic protocol for I-131 rhTSH-stimulated ablation therapy in patients with renal failure.
Topics: Adult; Aged; Clinical Protocols; Diabetes Mellitus, Type 1; Female; Granulomatosis with Polyangiitis | 2006 |
Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis.
Topics: Azathioprine; Eye Diseases; Female; Granulomatosis with Polyangiitis; Humans; Kidney; Middle Aged; P | 1994 |
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexameth | 1999 |